Unusual Machines Inc (AMEX:UMAC) does about 1.12M shares in volume on a normal day but saw 5642228 shares change hands in the recent trading day. The company now has a market cap of 163.38M USD. Its current market price is $6.58, marking an increase of 19.20% compared to the previous close of $5.52. The 52 week high reached by this stock is $23.62 whilst the lowest price level in 52 weeks is $1.13.
The consensus objective for the share price is $18.00, suggesting that the stock has a potential upside of 63.44% over the period.
FactSet Research has provided data showing that 1 brokerages have issued ratings for the stock. 0 analysts have rated it as a sell, while 0 advise that it is a overweight. 1 analysts have rated it as a buy and 0 have advised that investors hold their positions. The consensus recommendation rating is Buy and Wall Street’s advice is for investors to Strong Buy the stock.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on December 18, 2024 when Maxim Group initiated the stock to “Buy” and issued a price target of $18.
The current price level is 24.55%, 16.15%, and 2.41% away from its SMA20, SMA50, and SMA200 respectively, with the UMAC price moving below the 50-day SMA on current market day. Unusual Machines Inc (UMAC) stock is up 27.52% over the week and -4.78% over the past month. Its price is -60.88% year-to-date and 387.41% over the past year.
The company’s next earnings report forecasts estimating quarterly EPS at -0.08 and -0.38 for whole year. Expected sales for next quarter are $2.88M, which analysts say will come at $10.94M for the current fiscal year and next year at $20.64M. In addition, estimates put the company’s current quarterly revenue at an average of $1.81M.
To reach the target analysts have set, the stock logically needs to grow 63.44 percent from here.
Outstanding shares total 24.83M with insiders holding 9.97% of the shares and institutional holders owning 4.90% of the company’s common stock. The company has a return on investment of -211.55% and return on equity of -183.96%. The beta has a value of 24.86. Price to book ratio is 6.97 and price to sales ratio is 23.37.
